HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
(E)- ((3- cyclopentyloxy- 4- methoxyphenyl)methylene)- hydrazinecarboxamide
a type IV phosphodiesterase inhibitor
Also Known As:
CJ-10882
Networked:
1
relevant articles (
0
outcomes,
0
trials/studies)
Bio-Agent Context: Research Results
Organic Chemicals: 133
Hydrocarbons: 1713
Cyclic Hydrocarbons: 97
Alicyclic Hydrocarbons: 1
Cycloparaffins: 6
Cyclopentanes: 58
(E)-((3-cyclopentyloxy-4-methoxyphenyl)methylene)-hydrazinecarboxamide: 1
Hydrazines: 379
(E)-((3-cyclopentyloxy-4-methoxyphenyl)methylene)-hydrazinecarboxamide: 1
Experts
1.
Han, Junghee
: 1 article (03/2004)
2.
Kim, Byungbae
: 1 article (03/2004)
3.
Kim, Jong-Choon
: 1 article (03/2004)
4.
Shin, Ho-Chul
: 1 article (03/2004)
Related Diseases
1.
Vomiting
03/01/2004 - "
The 4-week repeated oral doses of CJ-10882 resulted in salivation, vomiting, and atrophy of the thymus.
"
2.
Atrophy
03/01/2004 - "
The 4-week repeated oral doses of CJ-10882 resulted in salivation, vomiting, and atrophy of the thymus.
"